-
Published16/02/2024
-
Deadline25/01/2026
-
Opening of tenders25/01/2026
-
Today24/09/2026
Utilities
- indicates text translated automatically in your browsing language
Conclusion of a non-exclusive discount agreement pursuant to § 130a(8) SGB V on medicinal products with the combination of active ingredients from oxycodon and naloxon (ATC code: N02AA55).
Conclusion of a non-exclusive discount agreement pursuant to § 130a(8) SGB V on medicinal products with the combination of active ingredients from oxycodon and naloxon (ATC code: N02AA55) during the period from 1.4.2024 to 31.3.2026, with the possibility to conclude contracts at any time during the term (“open-house model”).
Type: price
Description:
Weight (percentage, exact):
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.